Daiichi Sankyo Seeking Small Biotech Acquisitions In Europe
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo is scanning Europe for potential acquisitions that would help the Japanese company expand its market reach and enhance its product pipeline. Daiichi will focus on smaller biotechnology companies that have a strong oncology focus and a promising pipeline